| Invited commentary—genetic counselor's ethical and professional duty to discuss DTC tests |
|
|
|
|
|
|
|
|
|
| Seminars in medical genetics: Toward evidence‐based genetic counseling |
|
|
|
|
|
|
|
|
|
| Genetic counselors and research: Current practices and future directions |
|
|
|
|
|
|
|
|
|
| Uncertainty and perceived personal control among parents of children with rare chromosome conditions: The role of genetic counseling |
|
|
|
|
|
|
|
|
|
| Referral to cancer genetic counseling: Are there stages of readiness? |
|
|
|
|
|
|
|
|
|
| Ethical and clinical practice considerations for genetic counselors related to direct‐to‐consumer marketing of genetic tests |
|
|
|
|
|
|
|
|
|
| Through the viewfinder: Positive Exposure a year later |
|
|
|
|
|
|
|
|
|
| Uncertainty in<i>BRCA1</i>cancer susceptibility testing |
|
|
|
|
|
|
|
|
|
| Lost in transition: Challenges in the expanding field of adult genetics |
|
|
|
|
|
|
|
|
|
| Tolerance for uncertainty and perceived risk among women receiving uninformative<i>BRCA1/2</i>test results |
|
|
|
|
|
|
|
|
|
| The Genetic Counseling Video Project (GCVP): Models of practice |
|
|
|
|
|
|
✓ |
✓ |
varying ethnicity |
| Defining and redefining the scope and goals of genetic counseling |
|
|
|
|
|
|
|
|
|
| Current perspectives on Down syndrome: Selected medical and social issues |
|
|
|
|
|
|
|
|
|
| Down syndrome: Common otolaryngologic manifestations |
|
|
|
|
|
|
|
|
|
| Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome |
|
|
|
|
|
|
|
|
|
| The proteins of human chromosome 21 |
|
|
|
|
|
|
|
|
|
| Breaking difficult news in a newborn setting: Down syndrome as a paradigm |
|
|
|
|
|
|
|
|
|
| Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome |
|
|
|
|
|
|
|
|
|
| Current dilemmas in Down syndrome clinical care: Celiac disease, thyroid disorders, and atlanto‐axial instability |
|
|
|
|
|
|
|
|
|
| Clinical trials in children with Down syndrome: Issues from a cognitive research perspective |
|
|
|
|
|
|
|
|
|
| What the other children are thinking: Brothers and sisters of persons with Down syndrome |
|
|
|
|
|
|
|
|
|
| The genetic tyrosinemias |
|
|
|
|
|
|
|
|
|
| Inborn errors of metabolism: New challenges with expanded newborn screening programs |
|
|
|
|
|
|
|
|
|
| Biochemical findings in common inborn errors of metabolism |
|
|
|
|
|
|
|
|
|
| Disorders of carnitine transport and the carnitine cycle |
|
|
|
|
|
|
|
|
|
| Glutaric acidemia type 1 |
|
|
|
|
|
|
|
|
|
| Methylmalonic and propionic aciduria |
|
|
|
|
|
|
|
|
|
| Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency |
|
|
|
|
|
|
|
|
|
| Isovaleric acidemia: New aspects of genetic and phenotypic heterogeneity |
|
|
|
|
|
|
|
|
|
| Gap junction diseases of the skin: Am J Med Genet 131C: 12–19 |
|
|
|
|
|
|
|
|
|
| Clinical and molecular overlap in overgrowth syndromes |
|
|
|
|
|
|
|
|
|
| Etiologic yield of autistic spectrum disorders: A prospective study |
|
|
|
|
|
|
|
|
|
| Mouse models of autism spectrum disorders: The challenge for behavioral genetics |
|
|
|
|
|
|
|
|
|
| Genetics of autistic spectrum disorders |
|
|
|
|
|
|
|
|
|
| Autism spectrum disorders: Molecular genetic advances |
|
|
|
|
|
|
|
|
|
| Genetic counseling and ethical issues for autism |
|
|
|
|
|
|
|
|
|
| Current perspectives on the genetic analysis of autism |
|
|
|
|
|
|
|
|
|
| The yield of subtelomeric FISH analysis in the evaluation of autistic spectrum disorders |
|
|
|
|
|
|
|
|
|
| Advances in autism neuroimaging research for the clinician and geneticist |
|
|
|
|
|
|
|
|
|